The Clorox Company (NYSE:CLX) Shares Sold by Stephens Inc. AR

Stephens Inc. AR lessened its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 11.9% during the fourth quarter, HoldingsChannel reports. The firm owned 3,135 shares of the company’s stock after selling 422 shares during the period. Stephens Inc. AR’s holdings in Clorox were worth $509,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of CLX. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the third quarter worth about $27,000. Continuum Advisory LLC lifted its stake in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new position in shares of Clorox during the third quarter worth about $48,000. Finally, Friedenthal Financial acquired a new position in shares of Clorox during the third quarter worth about $49,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 1.9 %

NYSE:CLX opened at $147.91 on Friday. The firm has a market capitalization of $18.31 billion, a PE ratio of 40.41, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The stock has a 50 day moving average of $159.55 and a 200-day moving average of $159.13. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the firm earned $2.16 earnings per share. Analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th were given a dividend of $1.22 per share. The ex-dividend date was Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.30%. Clorox’s dividend payout ratio is presently 133.33%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CLX shares. Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Wells Fargo & Company lifted their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. DA Davidson dropped their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Finally, Evercore ISI boosted their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and an average target price of $158.21.

Check Out Our Latest Stock Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.